A new trading day began on Tuesday, with Immuneering Corp (NASDAQ: IMRX) stock price up 8.12% from the previous day of trading, before settling in for the closing price of $5.91. IMRX’s price has ranged from $1.10 to $10.08 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -46.45% over the last five years. Meanwhile, its annual earnings per share averaged 30.54%. With a float of $48.82 million, this company’s outstanding shares have now reached $63.48 million.
The firm has a total of 66 workers. Let’s measure their productivity.
Immuneering Corp (IMRX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immuneering Corp is 24.39%, while institutional ownership is 41.88%. The most recent insider transaction that took place on Oct 03 ’25, was worth 50,025. In this transaction Director of this company bought 7,500 shares at a rate of $6.67, taking the stock ownership to the 156,766 shares. Before that another transaction happened on Oct 01 ’25, when Company’s Chief Accounting Officer bought 300 for $6.39, making the entire transaction worth $1,917. This insider now owns 27,533 shares in total.
Immuneering Corp (IMRX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 30.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.55% during the next five years compared to -46.45% drop over the previous five years of trading.
Immuneering Corp (NASDAQ: IMRX) Trading Performance Indicators
Here are Immuneering Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 24.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.78, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Immuneering Corp (IMRX)
Analysing the last 5-days average volume posted by the [Immuneering Corp, IMRX], we can find that recorded value of 2.5 million was better than the volume posted last year of 1.43 million. As of the previous 9 days, the stock’s Stochastic %D was 44.84%.
During the past 100 days, Immuneering Corp’s (IMRX) raw stochastic average was set at 48.61%, which indicates a significant decrease from 69.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.40 in the past 14 days, which was lower than the 0.59 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.42, while its 200-day Moving Average is $4.20. Now, the first resistance to watch is $6.76. This is followed by the second major resistance level at $7.12. The third major resistance level sits at $7.54. If the price goes on to break the first support level at $5.98, it is likely to go to the next support level at $5.56. Now, if the price goes above the second support level, the third support stands at $5.20.
Immuneering Corp (NASDAQ: IMRX) Key Stats
With a market capitalization of 412.60 million, the company has a total of 64,570K Shares Outstanding. Currently, annual sales are 0 K while annual income is -61,040 K. The company’s previous quarter sales were 0 K while its latest quarter income was -14,960 K.
